UK Companies House feature
IPSCO LIMITED
Cash
—
Latest balance sheet
Net assets
-£18M
-11.5% vs 2024
Employees
6
Average over period
Profit before tax
—
Period ending 2025-02-28
Profile
- Company number
- 09277923
- Status
- Active
- Incorporation
- 2014-10-23
- Last accounts made up
- 2025-02-28
- Account category
- GROUP
- Primary SIC
- 21200
- Hubs
- UK Healthcare
Net assets
5-year trend · vs UK Healthcare median
Accounts
5-year trend · latest 2025-02-28
| Metric | Trend | 2021-02-28 | 2022-02-28 | 2023-02-28 | 2024-02-28 | 2025-02-28 |
|---|---|---|---|---|---|---|
| Turnover | — | — | — | — | — | |
| Operating profit | — | — | — | — | — | |
| Profit before tax | — | — | — | — | — | |
| Net profit | — | — | — | -£2,237,338 | -£1,894,144 | |
| Cash | £0 | £0 | £0 | — | — | |
| Total assets less current liabilities | — | — | — | — | — | |
| Net assets | — | — | — | -£16,401,965 | -£18,296,109 | |
| Equity | — | — | -£32,566,101 | -£16,401,965 | -£18,296,109 | |
| Average employees | — | — | — | — | 6 | |
| Wages | — | — | — | £0 | £0 |
Values shown as filed in iXBRL accounts. — indicates the figure was not present in the extracted filing (either not filed under that concept or absent from the period). About these numbers
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102
- Reporting scope
- Consolidated (group)
- Auditor
- Gerald Edelman LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“As a result of the above the directors have a reasonable expectation that the Group and Company has adequate resources to continue in operational existence for the foreseeable future, being a period of not less than twelve months from the date of approval of these financial statements, and continue to adopt the going concern basis of accounting in preparing the financial statements.”
Subsidiaries
- Vertical Pharma Resources Limited · 100% held · Manufacture and supply of special pharmaceutical products
- Intergrated Pharmaceutical Services (IPS) Limited · 100% held · Holding company
Significant events
- “The Group's turnover includes £27.6M (Year ended 28 February 2024 - £12.2M) from the sales of medicinal cannabis, and correspondingly £21.2M (Year ended 28 February 2024 - £9.8M) to cost of sales.”
- “Subsequent to the year end, the Group's main loan note holders formally extended the repayment date of these loans from 30 June 2025 to 30 June 2028 and the financial covenants amended to create sufficient headroom against base case forecast.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
6 active · 2 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| AGARWAL, Sandeep | Director | 2025-07-01 | Nov 1979 | British |
| COOK, Grahame David | Director | 2023-04-14 | Apr 1958 | British |
| DUTTA, Soimitra Tony | Director | 2018-09-27 | Apr 1963 | British |
| PARKER, James, Dr | Director | 2019-05-01 | Aug 1955 | British |
| PATANI, Vishal | Director | 2018-09-27 | Sep 1977 | British |
| PATEL, Ashokkumar Dahyabhai | Director | 2014-10-23 | Feb 1956 | British |
Show 2 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| JONES OWEN, David | Director | 2014-11-19 | 2015-07-31 |
| PENFOLD, Jonathan Mark | Director | 2016-06-23 | 2019-05-10 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Mr Ashokkumar Dahyabhai Patel | Individual | Shares 50–75% | 2016-12-04 | Active |
Filing timeline
Last 20 of 74 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2026-01-23 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2025-07-29 | AA | accounts | accounts with accounts type group |
| 2025-07-10 | AP01 | officers | appoint person director company with name date |
| 2025-01-27 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-06-27 | AA | accounts | accounts with accounts type group |
| 2024-01-08 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-01-03 | AA | accounts | accounts with accounts type group |
| 2023-07-14 | AA | accounts | accounts with accounts type group |
| 2023-06-19 | AP01 | officers | appoint person director company with name date |
| 2023-01-26 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2022-01-17 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2022-01-08 | AA | accounts | accounts with accounts type group |
| 2021-06-09 | AA | accounts | accounts with accounts type small |
| 2021-05-11 | DISS40 | gazette | gazette filings brought up to date |
| 2021-05-04 | GAZ1 | gazette | gazette notice compulsory |
| 2021-01-21 | CS01 | confirmation-statement | confirmation statement with updates |
| 2020-07-06 | MA | incorporation | memorandum articles |
| 2020-07-06 | RESOLUTIONS | resolution | resolution |
| 2020-07-06 | SH06 | capital | capital cancellation shares |
| 2020-07-06 | SH03 | capital | capital return purchase own shares |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory